China Food and Drug Administration (CFDA) issued the Amendment to the Provisions for In-vitro Diagnostic Reagent Registration (CFDA Order No. 30) on January 25, 2017, which shall come into effect as of the date of promulgation.

For more information of this Order, please contact with us.